Antineoplastic agents
Ref: 4Z-M-088010
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-C-3551
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-S-2744
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-N-3127
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-F-5321
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-R-093046
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-C-123010
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-D-7739
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-V-040008
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-C-123011
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-I-0948
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-M-088003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-F-5320
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-A-188023
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-C-123012
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-D-3045
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-D-7759
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-E-28106
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Ref: 4Z-M-846
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 22 Oct 2024
Bevacizumab
CAS:216974-75-3
Ipilimumab targets CTLA-4, an immune checkpoint inhibitor. Bevacizumab binds to VEGF-A isoforms.
Purity:
98.50% - SDS-PAGE:95.2%;SEC-HPLC:95.4%
Color and Shape:
Solid
Molecular weight:
149 kDa
Ref: TM-T9904
1mg | 127.00 € | ||
2mg | 202.00 € | ||
5mg | 374.00 € |
Estimated delivery in United States, on Tuesday 22 Oct 2024